A Non-interventional Cohort Safety Study of Patients With hATTR-PN — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Non-interventional Cohort Safety Study of Patients With hATTR-PN — Stella

Recruiting

Back to Hereditary Transthyretin Amyloidosis With Polyneuropthy trials

Trial locations(26 sites)

Bulgaria

Study Centre, Sofia

Cyprus

Study Centre, Égkomi, Nicosia

France

Study Center, Lille, Cedex

Study Center, Nice, Romaine

Study Centre, Nantes

Key details

Sponsor

Akcea Therapeutics

Collaborators

United BioSource, LLC

Enrollment target

~240 participants

Started

September 2021

Primary completion

March 2036

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.